Target intelligence / Profile preview

Selectins and neutrophil elastase

Molecular classification
Adhesion molecule, Enzyme, Serine protease
01

Overview

Selectins and neutrophil elastase represent two distinct but functionally linked components of the inflammatory cascade, particularly in the context of leukocyte recruitment and tissue damage. Selectins (E, L, and P) are cell surface glycoproteins that mediate the initial rolling of neutrophils and other leukocytes on the vascular endothelium, which is a prerequisite for firm adhesion and extravasation into inflamed tissues. Once neutrophils reach the site of inflammation, they release neutrophil elastase, a potent serine protease capable of degrading various extracellular matrix components such as elastin and collagen, as well as activating other pro-inflammatory mediators. Therapeutic strategies targeting this axis aim to both prevent the influx of inflammatory cells and mitigate the subsequent proteolytic damage they cause. This dual-pronged approach is primarily investigated for chronic inflammatory conditions of the lung, such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis, where excessive neutrophil activity is a hallmark of disease progression.

Other names
E-selectin (SELE)L-selectin (SELL)P-selectin (SELP)Neutrophil elastase (ELANE)Human neutrophil elastase (HNE)CD62ECD62LCD62PLeukocyte elastase
02

Mechanism of action

Inhibition of selectin-mediated leukocyte rolling and adhesion to the endothelium, combined with the inhibition of neutrophil elastase-mediated extracellular matrix degradation and pro-inflammatory signaling.

03

Biological functions

Cell adhesionImmune responseProteolysisInflammationLeukocyte recruitmentExtracellular matrix degradation
04

Disease associations

InflammationChronic obstructive pulmonary disease (COPD)AsthmaAcute respiratory distress syndrome (ARDS)Cystic fibrosisSickle cell diseasePsoriasis
05

Safety considerations

Potential for increased susceptibility to bacterial infectionsImpaired wound healingBleeding risk (associated with P-selectin inhibition)
06

Interacting drugs

Bimosiamose (TBC-1269)

5 more in the full profile.

07

Biomarkers

Soluble P-selectin (sP-selectin)Soluble E-selectin (sE-selectin)Plasma desmosineNeutrophil elastase-derived fibrin degradation productsSputum neutrophil count

Beyond the preview

Go deeper on Selectins and neutrophil elastase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selectins and neutrophil elastase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call